Delphinus Medical Technologies logo

Delphinus Medical Technologies

Delphinus Medical Technologies is commercializing an ultrasound-based, diagnostic imaging system for the early detection of breast cancer.
Novi, MI

CEO: Mark Forchette
Arboretum Lead: Paul McCreadie

October 12, 2021 in Delphinus, Home Page, News Page

Delphinus Receives FDA Approval for its SoftVue 3D Whole Breast Ultrasound Tomography System

Delphinus Medical Technologies, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) of its SoftVue™ 3D Whole Breast Ultrasound Tomography System (SoftVue™) for…
Read More
July 31, 2019 in Delphinus

Rachel Brem, M.D. Appointed to Delphinus Board of Directors

Delphinus Medical Technologies, Inc., the leader in advanced breast ultrasound technology, announced today that Rachel Brem, M.D, has joined the company’s board of directors, effective immediately.
Read More